The serum concentrations of chemokine cxcl12 and its specific receptor cxcr4 in patients with esophageal cancer

Disease Markers

Volumn 2016, Issue , 2016, Pages

  Łukaszewicz Zając, Marta ^a   Mroczko, Barbara ^a   Kozłowski, Mirosław ^a   Szmitkowski, Maciej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1; TUMOR ANTIGEN; CXCL12 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISTANT METASTASIS; ENZYME ASSAY; ESOPHAGUS CANCER; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CHEMOKINE CXCL12; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTORS, CXCR4;

EID: 84962262393     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2016/7963895     Document Type: Article

References (30)

1. D. Raman, P. J. Baugher, Y. M. Thu, and A. Richmond, "Role of chemokines in tumor growth, " Cancer Letters, vol. 256, no. 2, pp. 137-165, 2007.
2. M. S. Shrivastava, Z. Hussain, O. Giricz et al. , "Targeting chemokine pathways in esophageal adenocarcinoma, " Cell Cycle, vol. 13, no. 21, pp. 3320-3327, 2014.
3. A. Rot and U. H. von Andrian, "Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells, " Annual Review of Immunology, vol. 22, pp. 891-928, 2004.
4. R. M. Ransohoff, "Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology, " Immunity, vol. 31, no. 5, pp. 711-721, 2009.
5. M. J. Domper Arnal, A. Ferrandez Arenas, and A. Lanas Arbeloa, "Esophageal cancer: risk factors, screening and endoscopic treatment in western and eastern countries, " World Journal of Gastroenterology, vol. 21, pp. 7933-7943, 2015.
6. R. Siegel, D. Naishadham, and A. Jemal, "Cancer statistics, 2013, " CA:ACancer Journal forClinicians, vol. 63, no. 1, pp. 11-30, 2013.
7. K. D. Crew and A. I. Neugut, "Epidemiology of upper gastrointestinal malignancies, " Seminars in Oncology, vol. 31, no. 4, pp. 450-464, 2004.
8. H. Pohl and H. G. Welch, "The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence, " Journal of the National Cancer Institute, vol. 97, no. 2, pp. 142-146, 2005.
9. M. Arnold, I. Soerjomataram, J. Ferlay, and D. Forman, "Global incidence of oesophageal cancer by histological subtype in 2012, " Gut, vol. 64, no. 3, pp. 381-387, 2015.
10. R. S. Holmes and T. L. Vaughan, "Epidemiology and pathogenesis of esophageal cancer, " Seminars in Radiation Oncology, vol. 17, no. 1, pp. 2-9, 2007.
11. P. Lao-Sirieix and R. C. Fitzgerald, "Screening for oesophageal cancer, " Nature Reviews Clinical Oncology, vol. 9, no. 5, pp. 278-287, 2012.
12. L. R. Lundell, "Etiology and risk factors for esophageal carcinoma, " Digestive Diseases, vol. 28, no. 4-5, pp. 641-644, 2010.
13. S. T. Mayne and S. A. Navarro, "Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans, " Journal of Nutrition, vol. 132, no. 11, pp. 3467S-3470S, 2002.
14. S. Motoyama, M. Miura, Y. Hinai et al. , "CRP genetic polymorphism is associated with lymph nodemetastasis in thoracic esophageal squamous cell cancer, " Annals of Surgical Oncology, vol. 16, no. 9, pp. 2479-2485, 2009.
15. K. Sasaki, S. Natsugoe, S. Ishigami et al. , "Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma, " Oncology Reports, vol. 21, no. 1, pp. 65-71, 2009.
16. D. F. Wang, N. Lou, C. G. Zeng, X. Zhang, and F. J. Chen, "Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma, " Ai Zheng, vol. 28, no. 2, pp. 154-158, 2009.
17. J. T. Kaifi, E. F. Yekebas, P. Schurr et al. , "Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer, " Journal of the National Cancer Institute, vol. 97, no. 24, pp. 1840-1847, 2005.
18. C. L. Lu, Y. Ji, D. Ge, J. Guo, and J. Y. Ding, "The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer, " Diseases of the Esophagus, vol. 24, no. 4, pp. 283-290, 2011.
19. M. Lukaszewicz-Zajac, B. Mroczko, and M. Szmitkowski, "Chemokines and their receptors in esophageal cance-the systematic review and future perspectives, " Tumor Biology, vol. 36, no. 8, pp. 5707-5714, 2015.
20. J. R. Jass and L. H. Sobin, "Histological typing of intestinal tumors, " in WHO International Histological Classification of Tumors, Springer, New York, NY, USA, 1989.
21. M. Lukaszewicz-Zajac, B. Mroczko, M. KozLowski et al. , "Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus), " Journal of Clinical Laboratory Analysis, vol. 26, no. 2, pp. 73-81, 2012.
22. M. Lukaszewicz-Zajac, B. Mroczko, M. KozLowski, J. Niklinski, J. Laudanski, and M. Szmitkowski, "Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers, " Clinical Chemistry and Laboratory Medicine, vol. 48, no. 10, pp. 1467-1473, 2010.
23. M. Lukaszewicz-Zajac, B. Mroczko, M. KozLowski, J. Niklinski, J. Laudanski, and M. Szmitkowski, "Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients, " Diseases of the Esophagus, vol. 25, no. 3, pp. 242-249, 2012.
24. B. Mroczko, M. KozLowski, M. Groblewska et al. , "The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients, " Clinica Chimica Acta, vol. 389, no. 1-2, pp. 61-66, 2008.
25. M. Krzystek-Korpacka, M. Matusiewicz, D. Diakowska et al. , "Elevation of circulating interleukin-8 is related to lymph node and distant metastases in esophageal squamous cell carcinomas-implication for clinical evaluation of cancer patient, " Cytokine, vol. 41, no. 3, pp. 232-239, 2008.
26. I. Gockel, C. C. Schimanski, C. Heinrich et al. , "Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma, " BMC Cancer, vol. 6, article 290, 2006.
27. M. Zamanian-Azodi, M. Rezaei-Tavirani, H. Hasanzadeh et al. , "Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach, " Gastroenterology and Hepatology from Bed to Bench, vol. 8, no. 1, pp. 6-18, 2015.
28. J. Zhang, Z. Zhu, Y. Liu et al. , "Diagnostic value of multiple tumor markers for patients with esophageal carcinoma, " PLoS ONE, vol. 10, no. 2, Article IDe0116951, 2015.
29. S. Lawicki, G. E. Bedkowska, E. Gacuta-Szumarska, and M. Szmitkowski, "The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and subtypes of epithelial ovarian tumors, " Journal of Ovarian Research, vol. 6, article 45, 2013.
30. B. R. Keeley, F. Islami, A. Pourshams et al. , "Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer, " Cancer Science, vol. 105, no. 9, pp. 1205-1211, 2014.